secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001193125-24-087326
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics adopts non-qualified deferred compensation plan for executives and directors
--------------------------------------------------------------------------------

- Plan effective April 1, 2024; allows deferral of salary, fees, bonuses, and time-based RSUs.
- Participation limited to select management, highly compensated employees, and non-employee directors.
- Company may make matching or discretionary contributions; elective deferrals and matching fully vested.
- Payments generally made after separation from service or at elected in-service payment date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/0001193125-24-087326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/d819564d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-087326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer